Page last updated: 2024-10-31

midazolam and Diaphragmatic Paralysis

midazolam has been researched along with Diaphragmatic Paralysis in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yashiki, M1
Miyazaki, T1
Iwasaki, Y1
Taniguchi, T1
Kojima, T1

Other Studies

2 other studies available for midazolam and Diaphragmatic Paralysis

ArticleYear
Total spinal block after local anesthetic administration through the wrong access port of a spinal infusion pump.
    Revista espanola de anestesiologia y reanimacion, 2018, Volume: 65, Issue:4

    Topics: Anesthetics, Local; Bupivacaine; Clinical Protocols; Emergencies; Equipment Failure; Humans; Infusio

2018
[A case of suicide by an intravenous injection of pancuronium].
    Nihon hoigaku zasshi = The Japanese journal of legal medicine, 1992, Volume: 46, Issue:4

    Topics: Adult; Asphyxia; Chromatography, Gas; Humans; Injections, Intravenous; Male; Midazolam; Pancuronium;

1992